Dr. Reddy's Laboratories Ltd. ADR buy HSBC Holdings plc
Start price
05.06.25
/
50%
€13.80
Target price
05.06.26
€14.80
Performance (%)
-18.84%
End price
06.06.26
-
Summary
This prediction is currently being closed. The prediction for Dr. Reddy's Laboratories Ltd. ADR disappoints with a performance of -18.84%. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | -2.609% | -2.609% | -11.111% |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by HSBC_Holdings_plc for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Ratings data for RDY provided by MarketBeat
In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Die von HSBC_Holdings_plc gewählte maximale Laufzeit wurde überschritten